ArcticZymes signs new supply agreement for enzyme, Cod UNG
(Tromsø 13. December 2018) Biotec Pharmacon’s (OSE: Biotec) subsidiary ArcticZymes has signed a supply agreement with a major Japanese company for its product Cod UNG.ArcticZymes AS, a leader in the development and commercialization of enzymes applied to molecular diagnostics, gene therapy, and protein purification, announces a new dual track supply agreement for its specialized enzyme, Cod UNG. ArticZymes’ Japanese customer intends to develop and manufacture molecular biology assay products containing Cod UNG for the research market and molecular diagnostic kits. In addition, the